Pages that link to "Item:Q2858002"
From MaRDI portal
The following pages link to Optimal adaptive two-stage designs for phase II cancer clinical trials (Q2858002):
Displaying 15 items.
- Two-stage design for phase II oncology trials with relaxed futility stopping (Q1747566) (← links)
- On optimal subset designs for phase II clinical trials with both total response and disease control (Q2242847) (← links)
- Random norming AIDS analysis of non-linear regression models with sequential informative dose selection (Q2301071) (← links)
- Randomized phase II cancer clinical trials (Q2852232) (← links)
- Adjusting Simon's optimal two‐stage design for heterogeneous populations based on stratification or using historical controls (Q3299096) (← links)
- Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials (Q3442979) (← links)
- MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (Q4512728) (← links)
- An optimal design in a two-stage ethical allocation based on <i>U</i>-statistics (Q5083343) (← links)
- Optimal exact design of double acceptance sampling plans by attributes (Q5107524) (← links)
- Adaptive two-stage optimal designs for phase II clinical studies that allow early futility stopping (Q5227806) (← links)
- A batch‐effect adjusted Simon's two‐stage design for cancer vaccine clinical studies (Q6076520) (← links)
- Bayesian enhancement two-stage design with error control for phase II clinical trials (Q6617391) (← links)
- Exact confidence limits after a group sequential single arm binary trial (Q6627784) (← links)
- Optimal planning of adaptive two-stage designs (Q6628099) (← links)
- New results on optimal conditional error functions for adaptive two-stage designs (Q6662618) (← links)
